Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000455666 | SCV000540533 | benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: MAF. Associated with susceptibility to infections, rheumatoid arthritis. Some functional evidence to show reduced IFN and TNF secretion in response to stimulation. This may be a risk allele, but unlikely to cause disease on its own |
Genome Diagnostics Laboratory, |
RCV000610503 | SCV000743658 | likely benign | Immunodeficiency 83, susceptibility to viral infections | 2016-11-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001519768 | SCV001728696 | benign | Herpes simplex encephalitis, susceptibility to, 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001642535 | SCV001855996 | benign | not provided | 2019-10-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 29290528, 24371259, 26298326, 31445170, 28046022, 23240626, 17434873, 18325643, 22549436, 18753640, 20413676, 20472559, 20855885, 21093032, 19016379, 21216866, 22174453, 22537752, 22504413, 21712495, 25304972, 22024499) |
Fulgent Genetics, |
RCV002490456 | SCV002803130 | benign | Susceptibility to HIV infection; Immunodeficiency 83, susceptibility to viral infections | 2021-08-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003974868 | SCV004798456 | benign | TLR3-related condition | 2024-01-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
OMIM | RCV000034357 | SCV000058339 | protective | Susceptibility to HIV infection | 2018-08-08 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000610503 | SCV000734332 | benign | Immunodeficiency 83, susceptibility to viral infections | no assertion criteria provided | clinical testing |